a significant trendp = 0.220
NSAIDs use did not show a significant trend ( p = 0.220). 3.3.
NSAIDs use did not show a significant trend ( p = 0.220). 3.3.
Although there was a significantly increasing trend for the preoperative use of csDMARDs and bDMARDs + tsDMARDs, and a decreasing trend for inflammatory markers from trend analysis and intergroup comparisons (2002–2011 vs. 2012–2022), the overall percentage of preoperative use of csDMARDs and bDMARDs + tsDMARDs in our cohort was as low as 36.3% and 6.2%, respectively.
The use of glucocorticoids (GCs) before surgery demonstrated a significant decreasing trend while conventional synthetic disease‐modifying anti‐rheumatic drugs (csDMARDs) and biological DMARDs (bDMARDs) + targeted synthetic DMARDs (tsDMARDs) demonstrated an increasing trend.